✦ LIBER ✦

Real-World Application of the Roadmap Model in Chronic Hepatitis B Patients with Telbivudine Therapy

✍ Scribed by Yu, Hsien-Chung; Lin, Kung-Hung; Hsu, Ping-I; Tsay, Feng-Woei; Wang, Huay-Min; Tsai, Tzung-Jiun; Lai, Kwok-Hung

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of antiviral therapy with Telbiv

✍ T. D. Shi; J. M. Zhang; X. F. Wang; M. Chen; H. Sun; C. B. Chen; H. Ren 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 471 KB

A 1-Year Trial of Telbivudine, Lamivudin

✍ Ching-Lung Lai; Nancy Leung; Eng-Kiong Teo; Myron Tong; Florence Wong; Hie-Won H 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 203 KB

539 2-YEAR RESULTS OF TELBIVUDINE (LDT)

✍ T. Piratvisuth; P. Komolmit; T. Tanwandee; W. Sukeepaisarnjaroen; H.L. Chan; M.G 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB

PL-009 Combination of telbivudine and ad

✍ E.-Q. Chen; T.-Y. Zhou; H. Tang 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Modeling the cost-effectiveness of diffe

✍ Maria Buti; Max Brosa; Miguel A. Casado; Magdalena Rueda; Rafael Esteban 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 497 KB

620 THE INCREASED EXPRESSION OF 2B4 (CD2

✍ Y.-F. Jiang; W.-Y. Li; Q.-L. Jin; H.-Q. Yan; J.-Q. Niu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 68 KB